Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles

Springer Science and Business Media LLC - 1999
Rocío Fernández-Urrusuno1, Pilar Calvo2, Carmen Remuñán-López1, Jose Luis Vila-Jato1, María José Alonso1
1Department Pharmaceutical Technology, School of Pharmacy, Santiago de Compostela, Spain
2Faculté de Pharmacie, URA CNRS 1218, Université Paris Sud, Chatenay-Malabry, France

Tóm tắt

Purpose. To investigate the potential of chitosan nanoparticles as a system for improving the systemic absorption of insulin following nasal instillation. Methods. Insulin-loaded chitosan nanoparticles were prepared by ionotropic gelation of chitosan with tripolyphosphate anions. They were characterized for their size and zeta potential by photon correlation spectroscopy and laser Doppler anemometry, respectively. Insulin loading and release was determined by the microBCA protein assay. The ability of chitosan nanoparticles to enhance the nasal absorption of insulin was investigated in a conscious rabbit model by monitoring the plasma glucose levels. Results. Chitosan nanoparticles had a size in the range of 300−400 nm, a positive surface charge and their insulin loading can be modulated reaching values up to 55% [insulin/nanoparticles (w/w): 55/100]. Insulin association was found to be highly mediated by an ionic interaction mechanism and its release in vitro occurred rapidly in sink conditions. Chitosan nanoparticles enhanced the nasal absorption of insulin to a greater extent than an aqueous solution of chitosan. The amount and molecular weight of chitosan did not have a significant effect on insulin response. Conclusions. Chitosan nanoparticles are efficient vehicles for the transport of insulin through the nasal mucosa.

Từ khóa


Tài liệu tham khảo

C. R. Behl, H. K. Pimplaskar, A. P. Sileno, W. J. Xia, J. C. Gries, and V. D. Romeo. Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv. Drug Del. Rev. 29:117–133 (1998).

C. McMartin, L. E. F. Hutchinson, R. Hyde, and G. E. Peters. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pham. Sci. 76:535–540 (1987).

A. E. Pontirolli. Intranasal administration of calcitonin and other peptides: studies with different promoters. J. Contr. Rel. 13:247–251 (1990).

S. Hirai, T. Ikenaga, and T. Matsuzawa. Nasal absorption of insulin in dogs. Diabetes 27:296–299 (1978).

V. H. L. Lee. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Contr. Rel. 13:213–223 (1990).

N. F. Farraj, B. R. Johansen, S. S. Davis, and L. Illum. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Contr. Rel. 13:253–261 (1990).

K. Morimoto, K. Morisaka, and A. Kamada. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J. Pharm. Pharmacol. 37:134–136 (1985).

L. Illum. Drug delivery systems for nasal application. STP Pharma 3:594–598 (1987).

L. Ryden and P. Edman. Effect of polymers and microspheres on the nasal absorption of insulin in rats. Int. J. Pharm. 83:1–10 (1992).

L. Jian and L. W. Po. Effects of insulin and nasal absorption enhancers on ciliary activity. Int. J. Pharm. 95:101–104 (1993).

M. A. Wheatley, J. Dent, E. B. Wheeldon, and P. L. Smith. Nasal drug delivery: an in vitro characterization of transepithelial electrical properties and fluxes in the presence or absence of enhancers. J. Cont. Rel. 8:167–177 (1988).

N. G. M. Schipper, J. Verhoef, S. G. Romeijn, and F. W. H. M. Merkus. Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning. J. Contr. Rel. 21:173–186 (1992).

L. Illum, N. F. Farraj, and S. S. Davis. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1186–1189 (1994).

P. Artursson, T. Lindmark, S. S. Davis, and L. Illum. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1358–1361 (1994).

P. Calvo, C. Remuñan-Lopez, J. L. Vila-Jato, and M. J. Alonso. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Pol. Sci. 63:125–132 (1997).

P. Calvo, C. Remuñan-Lopez, J. L. Vila-Jato, and M. J. Alonso. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14:1431–1436 (1997).

P. Calvo, A. S. Boughaba, M. Appel, E. Fattal, M. J. Alonso, and P. Couvreur. Oligonucleotide-chitosan nanoparticles as new gene therapy vector. Proceed. 2nd World Meeting APGI/APV, Paris, 1998, pp. 1111–1112.

P. Dondeti, H. Zia, and T. E. Needham. In vivo evaluation of spray formulations of human insulin for nasal delivery. Int. J. Pharm. 122:91–105 (1995).

S. H. Mayor and L. Illum. Investigation of the effect of anaesthesia on nasal absorption of insulin in rats. Int. J. Pharm. 149:123–129 (1997).

R. Fernandez-Urrusuno, P. Calvo, J. L. Vila-Jato, and M. J. Alonso. Chitosan nanoparticles as carriers for mucosal administration of peptides. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 25:520–521 (1998).

T. J. Aspden, L. Illum, and O. Skaugrud. Chitosan as a nasal delivery system: evaluation of insulin absorption and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 4:23–31 (1996).

A. F. Kotzé, H. L. Lueßen, B. J. de Leeuw, B. G. de Boer, J. C. Verhoef, and H. E. Junginger. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Contr. Rel. 51:35–46 (1998).

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả